No insider purchase over the last 90 days. The latest, by 최규리, was filed 07 Apr 2026.
Who traded when
BuySaleSince the insiders bought
- -24.1%Entry ₩11,060 · Close 30 Oct 2026 ₩8,400
- -24.1%Entry ₩11,060 · Close 30 Oct 2026 ₩8,400
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,000 shares@ ₩10,777.000.017% mcap100.0% of flowShareKRXDART:20260407000455Canonical exit: 5 Jul 2026 (T+90)
- 0KRXDART:20260407003319
- 1,200,000 sharesShareKRXDART:20260407003398Canonical exit: 5 Jul 2026 (T+90)
- 2,400,000 sharesShareKRXDART:20260407003351
- ●Executives0DART
- 6,000 sharesShareKRXDART:20260129000105Canonical exit: 29 Apr 2026 (T+90)
- ShareKRXDART:20240827000460Canonical exit: 8 Apr 2024 (T+90)
- 1,500 sharesKRXDART:20240626000355
- ShareKRXDART:20240514000373
- ShareKRXDART:20231129001273
- ShareKRXDART:20231027000351
- ShareKRXDART:20231027000388
- ShareKRXDART:20230822000331
- ShareKRXDART:20230526000560
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20211008000151
- ShareKRXDART:20210730000161
- 1,500 sharesKRXDART:20210517001334
- ●Executives0DART
24 of 24 declarations
About Boditech Med Inc.
On April 6, 2026, two managers of 바디텍메드 (Boditech Med Inc.) bought, including 장덕환 (상무이사) for EUR 24,744, the only purchase with an amount in the record. 장덕환 signs 2 purchases, 최규리 (이사) one, and 박대균 (이사) one out of 9 filings. By contrast, the executive 최의열 (대표이사) filed 6, including 3 sales. The company files 5, with no trade.
In all, 4 purchases and 3 sales: 57% purchases, with no other amount. The 24 filings span March 10, 2021 to April 7, 2026: 4 in 2021, 5 in 2022, 6 in 2023, 3 in 2024 and 6 in 2026. In all, 17 are neither purchases nor sales.
Read moreShow less
The company, South Korean and active in health care, carries a KRW 195.4 billion capitalisation; insiders own 37.5% and 6 filers are listed. A trade is published 3 days later at the median. The 6 filings of the latest year include 3 purchases and one sale, and the company files 5 of the 24 itself.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
